Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
Recruiting · NCT06953349 · Observational (researchers observe without assigning treatment) · Lead sponsor: Barnet Dulaney Perkins Eye Centers
View the official record on ClinicalTrials.gov →Interventions studied
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
What this trial is about
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
- have Glaucoma
Exclusion criteria
- Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
- Patients with refractory CME or CME persisting 3 months or more post-operatively
- Patients with incomplete IOP, medication logs or VF data within post-operative period
- Prior incisional surgery or MIGS
Where it is running
1 location listed across 1 US state.
- Barnet Dulaney Perkins Eye Center - Mesa, Arizona, United States